$OXM

Oxford Industries Shares Fall 14.3% After Full-Year Guidance Cut

Oxford Industries (OXM) shares dropped 14.3% to $31.40 after cutting its full-year earnings forecast. Q2 revenue was $394.4M, beating estimates, but Q3 and full-year guidance fell short. CEO Tom Chubb cited Lilly Pulitzer's weak performance and softer consumer sentiment. OXM shares neared a 52-week low.

Original reporting
Published Sep 5, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 5, 2026, 1:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oxford Industries Shares Fall 14.3% After Full-Year Guidance Cut — source image
Decision brief

The 30-second read

$OXMBearishHigh
01

Why it matters

The guidance cut is a primary disclosure that caused a significant pre‑market price drop, indicating immediate trading relevance.

02

Market read

The news directly affects OXM and may influence broader consumer discretionary sentiment.

03

What to watch

Potential cost reductions and promotional initiatives at Lilly Pulitzer may mitigate downside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Oxford Industries reported Q2 FY2026 results and revised its outlook, citing weak Lilly Pulitzer performance and softer consumer sentiment.

Company-level read

Ticker impact

$OXMBearishHigh confidence
Context

Oxford Industries cut full-year EPS guidance and forecast a Q3 loss, causing a 14.3% pre‑market drop.

Expected impact

downward pressure, potential further decline toward 52‑week low

Evidence & confidence

The new guidance is materially below consensus and was released today, driving immediate price action.

Market effects

Apparel and discretionary consumer stocks may face pressure as weaker demand is highlighted.

U.S. equities see limited movement but the sector could underperform.

Minimal; impact confined to U.S. consumer discretionary space.

Counterpoint

If the brand turnaround succeeds, the stock could rebound sharply from oversold levels.

Key entities

  • Oxford Industries

    U.S. apparel retailer (ticker OXM) that issued the guidance cut.

  • Lilly Pulitzer

    Key brand within Oxford Industries cited as a weakness.

Related articles

MedAI 8/10

Oxford Industries, Inc. Q2 2026 Earnings Call Summary

Oxford Industries reported Q2 2026 earnings, with Tommy Bahama showing growth, Lilly Pulitzer struggling due to pricing shifts, and Johnny Was improving profitability. Adjusted gross margin expanded 140 bps. Full-year guidance was lowered due to Lilly Pulitzer's challenges and cautious consumer sentiment. The company plans to reshuffle Lilly Pulitzer's assortment by Spring 2027 and reduce capital expenditures to $60 million. Inventory decreased 4% on a FIFO basis.

$OXMMedAI 8/10

Oxford Industries Q2 Earnings Call Highlights

Oxford Industries (OXM) reported Q2 sales growth at Tommy Bahama offsetting declines elsewhere. Adjusted gross margin rose to 63.1%, while adjusted EBITDA increased to $45M. The company received $42M in tariff refunds, aiding cash flow and debt reduction. Oxford lowered its full-year outlook, expecting a low-single-digit sales decline and adjusted EPS of $1.60-$2.00. Lilly Pulitzer's reset is planned for spring 2027, with targeted promotions expected to support inventory sell-through.

$OXMHighAI 8/10

Why Oxford Industries (OXM) Stock Is Falling Today

Oxford Industries (OXM) stock fell 17.7% after reporting Q2 2026 net sales of $394.4M, down 2.2% YoY, and lowering full-year EPS guidance to $1.60-$2.00 due to challenges at Lilly Pulitzer and macroeconomic pressures. Adjusted EPS rose to $1.34, while GAAP EPS included a $2.07 per-share benefit from a tariff refund. Tommy Bahama sales grew 0.8%, but Lilly Pulitzer and Johnny Was saw declines.

$OXMMed

OXM Q2 Deep Dive: Guidance Cut as Lilly Pulitzer Weighs on Mixed Portfolio

Oxford Industries (OXM) met Q2 revenue expectations at $394.4M, down 2.2% YoY, but Q3 guidance of $290M missed estimates by 7.5%. Non-GAAP EPS of $1.34 beat estimates. CEO Thomas Chubb cited strength in Tommy Bahama and challenges at Lilly Pulitzer, including assortment issues and higher promotions. Management expects Lilly Pulitzer's weakness to persist through 2026, with improvements delayed until spring 2027.